Your browser doesn't support javascript.
Repurposing anticancer drugs for the management of COVID-19.
El Bairi, Khalid; Trapani, Dario; Petrillo, Angelica; Le Page, Cécile; Zbakh, Hanaa; Daniele, Bruno; Belbaraka, Rhizlane; Curigliano, Giuseppe; Afqir, Said.
  • El Bairi K; Department of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco. Electronic address: k.elbairi@ump.ac.ma.
  • Trapani D; European Institute of Oncology, IRCCS, Milan, Italy.
  • Petrillo A; Medical Oncology Unit, Ospedale del Mare, Naples, Italy; University of Study of Campania "L.Vanvitelli", Naples, Italy.
  • Le Page C; Research Institute of McGill University Health Center (RI-MUHC), Montréal, QC, Canada.
  • Zbakh H; Center of Marine Sciences, University of Algarve, Ed. 7, Campus of Gambelas, 8005-139, Faro, Portugal.
  • Daniele B; Medical Oncology Unit, Ospedale del Mare, Naples, Italy.
  • Belbaraka R; Department of Medical Oncology, "Bioscience et Santé" Research Laboratory, Faculty of Medicine, Cadi Ayad University, Marrakesh, Morocco.
  • Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy; University of Milan, Department of Oncology and Hematology, Milan, Italy.
  • Afqir S; Department of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco.
Eur J Cancer ; 141: 40-61, 2020 12.
Article in English | MEDLINE | ID: covidwho-778792
ABSTRACT
Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion and thus is regarded as a global public health emergency. The existing therapeutic options for COVID-19 beyond the intensive supportive care are limited, with an undefined or modest efficacy reported so far. Drug repurposing represents an enthusiastic mechanism to use approved drugs outside the scope of their original indication and accelerate the discovery of new therapeutic options. With the emergence of COVID-19, drug repurposing has been largely applied for early clinical testing. In this review, we discuss some repurposed anticancer drugs for the treatment of COVID-19, which are under investigation in clinical trials or proposed for the clinical testing.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Repositioning / SARS-CoV-2 / COVID-19 Drug Treatment / Antineoplastic Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Eur J Cancer Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Repositioning / SARS-CoV-2 / COVID-19 Drug Treatment / Antineoplastic Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Eur J Cancer Year: 2020 Document Type: Article